The Trump administration’s December 2025 executive order directed expedited review of marijuana’s placement under the Controlled Substances Act, prompting the Department of Justice and DEA in April 2026 to issue an immediate final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III effective April 28. This partial rescheduling bypassed full rulemaking for qualifying medical categories while withdrawing prior hearing notices and launching an expedited administrative process. The DEA’s new hearing on broader rescheduling of all marijuana from Schedule I to Schedule III is scheduled to begin June 29, 2026, with firm procedural deadlines intended to accelerate any final rulemaking. Traders are monitoring hearing outcomes, potential litigation, and whether the administration completes broader reclassification before year-end deadlines referenced in related prediction markets.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트$765,952 거래량
6월 30일
2%
12월 31일
27%
$765,952 거래량
6월 30일
2%
12월 31일
27%
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
마켓 개설일: Feb 7, 2026, 5:04 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...The Trump administration’s December 2025 executive order directed expedited review of marijuana’s placement under the Controlled Substances Act, prompting the Department of Justice and DEA in April 2026 to issue an immediate final order moving FDA-approved marijuana products and state-licensed medical marijuana to Schedule III effective April 28. This partial rescheduling bypassed full rulemaking for qualifying medical categories while withdrawing prior hearing notices and launching an expedited administrative process. The DEA’s new hearing on broader rescheduling of all marijuana from Schedule I to Schedule III is scheduled to begin June 29, 2026, with firm procedural deadlines intended to accelerate any final rulemaking. Traders are monitoring hearing outcomes, potential litigation, and whether the administration completes broader reclassification before year-end deadlines referenced in related prediction markets.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문